一次性生物反应器市场－全球产业规模、份额、趋势、机会和预测，按产品、类型、细胞类型、分子、应用、用途、最终用户、地区和竞争细分，2020-2030 年

2024年，全球一次性生物反应器 (SUB) 市场规模为23亿美元，预计到2030年将达到47.5亿美元，预测期内复合年增长率为12.85%。市场成长的动力源自于研发活动的增加、合作的拓展以及对新型疫苗和疗法日益增长的需求。慢性病和传染病的发生率上升，以及单株抗体的不断发展，进一步推动了市场扩张。 SUB提供了一种可扩展且经济高效的传统不銹钢系统替代方案，使其在临床和商业生产中都具有吸引力。

例如，2022年1月，HaemaLogiX Ltd与Lonza合作生产了一批临床批次的KappaMab，这是一种针对κ骨髓瘤抗原的单株抗体，证明了SUB在高阶药物开发中的作用。此外，生物製剂的快速普及、政府对生物製剂研究的资助以及对个人化医疗的日益关注，正在推动全球製药和生物製药行业对SUB的需求。 SUB的优势包括降低污染风险、缩短週转时间以及降低清洁要求，使其在现代生物製程操作中日益不可或缺。

关键市场驱动因素

生物製药需求和生物相似药生产激增

主要市场趋势

数位科技在生物加工中的整合

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球一次性生物反应器市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依产品（一次性生物反应器系统、一次性培养基袋、一次性过滤组件、其他产品）
  • 依类型（搅拌槽式SUB、波浪诱导式SUB、鼓泡塔式SUB、其他SUB）
  • 依细胞类型（哺乳动物细胞、细菌细胞、酵母细胞、其他细胞）
  • 按分子（单株抗体、疫苗、基因改造细胞、干细胞、其他分子）
  • 按应用（研发、生物生产）
  • 依用途（实验室规模生产、中试规模生产、大规模生产）
  • 按最终用户（製药和生物製药公司、CROS 和 CMOS、学术和研究机构）
  • 按地区（北美、欧洲、亚太、南美、中东和非洲）
  • 按公司分类（2024）
• 市场地图
• 按产品
• 按类型
• 按细胞类型
• 按分子
• 按应用
• 按用途
• 按最终用户
• 按地区

第六章：北美一次性生物反应器市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲一次性生物反应器市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太一次性生物反应器市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美洲一次性生物反应器市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东和非洲一次性生物反应器市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 实验室自动化活动的需求不断成长
• 生物库越来越多地采用实验室资讯学
• 越来越多引入技术先进的软体服务
• 挑战
• 缺乏实验室资讯学整合标准
• 严格的规定

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：全球一次性生物反应器市场：SWOT 分析

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• ABEC, INC.
• Able Corporation & Biott Corporation.
• BBI-Biotech Gmbh.
• Cellexus Biosystems PLC.
• Celltainer Biotech BV.
• Danaher Corporation
• Distek Inc.
• Eppendorf AG.
• G&G Technologies, Inc.
• Getinge AB

第 16 章：策略建议

第17章调查会社について・免责事项

The Global Single-Use Bioreactors (SUBs) Market was valued at USD 2.30 billion in 2024 and is projected to reach USD 4.75 billion by 2030, growing at a CAGR of 12.85% during the forecast period. The market's growth is driven by increasing research and development activities, expanding collaborations, and heightened demand for novel vaccines and therapeutics. The rise in chronic and infectious diseases, along with the growing development of monoclonal antibodies, further supports market expansion. SUBs offer a scalable and cost-efficient alternative to traditional stainless-steel systems, making them attractive for both clinical and commercial manufacturing.

For instance, in January 2022, HaemaLogiX Ltd partnered with Lonza to manufacture a clinical batch of KappaMab, a monoclonal antibody targeting kappa myeloma antigen-demonstrating the role of SUBs in advanced drug development. Additionally, the rapid adoption of biologics, government funding for biologics research, and increased focus on personalized medicine are fostering demand for SUBs across global pharmaceutical and biopharmaceutical sectors. Their benefits, including reduced contamination risk, shorter turnaround times, and minimal cleaning requirements, make them increasingly indispensable in modern bioprocessing operations.

Key Market Drivers

Surge in Biopharmaceutical Demand and Biosimilar Production

The growing demand for biopharmaceutical products-particularly monoclonal antibodies, vaccines, and biosimilars-is a major driver of the single-use bioreactors market. These biologics are increasingly used to treat chronic diseases such as cancer, diabetes, and autoimmune disorders due to their targeted therapeutic effects and lower side effect profiles. SUBs offer a flexible and efficient production solution, reducing the need for time-consuming cleaning and sterilization compared to stainless-steel systems.

Supportive regulatory environments and rising public investment in biologics research are accelerating this shift. For instance, as of March 2024, the U.S. National Institutes of Health allocated USD 47.6 billion in funding, emphasizing biologics and biosimilar development. Similarly, the European Medicines Agency approved a notable number of monoclonal antibodies in 2023. These advancements, alongside favorable government policies, are promoting the adoption of SUBs to meet the evolving demands of large-scale and cost-effective biomanufacturing.

Key Market Trends

Integration of Digital Technologies in Bioprocessing

The integration of digital tools such as IoT, AI, and machine learning into SUB platforms is revolutionizing biomanufacturing practices. These technologies enable real-time monitoring, predictive analytics, and advanced process control-enhancing efficiency, product quality, and compliance.

Referred to as Bioprocessing 4.0, this evolution is being actively supported by regulatory agencies. For example, the U.S. FDA is encouraging the adoption of advanced manufacturing technologies to boost production resilience and safety. As a result, biopharmaceutical firms are increasingly investing in digitalized SUB systems, enabling smarter, faster, and more agile production processes. This synergy between single-use bioreactor platforms and digital transformation is expected to drive sustained improvements in scalability, traceability, and operational performance in the bioprocessing sector.

Key Market Players

• ABEC, INC.
• Able Corporation & Biott Corporation
• BBI-Biotech GmbH
• Cellexus Biosystems PLC
• Celltainer Biotech BV
• Danaher Corporation
• Distek Inc.
• Eppendorf AG
• G&G Technologies, Inc.
• Getinge AB

Report Scope:

In this report, the Global Single-Use Bioreactors Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Single-Use Bioreactors Market, By Product:

• Single use bioreactor systems
• Single use media bags
• Single use filtration assemblies
• Other products

Single-Use Bioreactors Market, By Type:

• Stirred tank SUB
• Wave induced SUB
• Bubble Column SUB
• Other SUB

Single-Use Bioreactors Market, By Type of Cell:

• Mammalian Cell
• Bacterial Cell
• Yeast Cell
• Other Cells

Single-Use Bioreactors Market, By Molecule:

• Monoclonal Antibodies
• Vaccines
• Gene Modified Cells
• Stem Cells
• Other molecules

Single-Use Bioreactors Market, By Application:

• Research and Development
• Bioproduction

Single-Use Bioreactors Market, By Usage:

• Lab scale production
• Pilot scale production
• Large scale production

Single-Use Bioreactors Market, By End User:

• Pharmaceutical and Biopharmaceutical companies
• CROSs & CMOS
• Academic and Research Institutes

Single-Use Bioreactors Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Single-Use Bioreactors Market.

Available Customizations:

Global Single-Use Bioreactors Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Single-Use Bioreactors Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
  • 5.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
  • 5.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
  • 5.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
  • 5.2.5. By Application (Research and Development, Bioproduction)
  • 5.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
  • 5.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
  • 5.2.8. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.9. By Company (2024)
• 5.3. Market Map
• 5.3.1 By Product
• 5.3.2 By Type
• 5.3.3 By Type of Cell
• 5.3.4 By Molecule
• 5.3.5 By Application
• 5.3.6 By Usage
• 5.3.7 By End User
• 5.3.5 By Region

6. North America Single-Use Bioreactors Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
  • 6.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
  • 6.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
  • 6.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
  • 6.2.5. By Application (Research and Development, Bioproduction)
  • 6.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
  • 6.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
  • 6.2.8. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Single-Use Bioreactors Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Type of Cell
      • 6.3.1.2.4. By Molecule
      • 6.3.1.2.5. By Application
      • 6.3.1.2.6. By Usage
      • 6.3.1.2.7. By End User
  • 6.3.2. Canada Single-Use Bioreactors Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Type of Cell
      • 6.3.2.2.4. By Molecule
      • 6.3.2.2.5. By Application
      • 6.3.2.2.6. By Usage
      • 6.3.2.2.7. By End User
  • 6.3.3. Mexico Single-Use Bioreactors Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Type of Cell
      • 6.3.3.2.4. By Molecule
      • 6.3.3.2.5. By Application
      • 6.3.3.2.6. By Usage
      • 6.3.3.2.7. By End User

7. Europe Single-Use Bioreactors Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
  • 7.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
  • 7.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
  • 7.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
  • 7.2.5. By Application (Research and Development, Bioproduction)
  • 7.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
  • 7.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
  • 7.2.8. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Single-Use Bioreactors Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Type of Cell
      • 7.3.1.2.4. By Molecule
      • 7.3.1.2.5. By Application
      • 7.3.1.2.6. By Usage
      • 7.3.1.2.7. By End User
  • 7.3.2. Germany Single-Use Bioreactors Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Type of Cell
      • 7.3.2.2.4. By Molecule
      • 7.3.2.2.5. By Application
      • 7.3.2.2.6. By Usage
      • 7.3.2.2.7. By End User
  • 7.3.3. United Kingdom Single-Use Bioreactors Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Type of Cell
      • 7.3.3.2.4. By Molecule
      • 7.3.3.2.5. By Application
      • 7.3.3.2.6. By Usage
      • 7.3.3.2.7. By End User
  • 7.3.4. Italy Single-Use Bioreactors Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Type of Cell
      • 7.3.4.2.4. By Molecule
      • 7.3.4.2.5. By Application
      • 7.3.4.2.6. By Usage
      • 7.3.4.2.7. By End User
  • 7.3.5. Spain Single-Use Bioreactors Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Type of Cell
      • 7.3.5.2.4. By Molecule
      • 7.3.5.2.5. By Application
      • 7.3.5.2.6. By Usage
      • 7.3.5.2.7. By End User

8. Asia-Pacific Single-Use Bioreactors Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
  • 8.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
  • 8.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
  • 8.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
  • 8.2.5. By Application (Research and Development, Bioproduction)
  • 8.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
  • 8.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
  • 8.2.8. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Single-Use Bioreactors Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Type of Cell
      • 8.3.1.2.4. By Molecule
      • 8.3.1.2.5. By Application
      • 8.3.1.2.6. By Usage
      • 8.3.1.2.7. By End User
  • 8.3.2. India Single-Use Bioreactors Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Type of Cell
      • 8.3.2.2.4. By Molecule
      • 8.3.2.2.5. By Application
      • 8.3.2.2.6. By Usage
      • 8.3.2.2.7. By End User
  • 8.3.3. Japan Single-Use Bioreactors Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Type of Cell
      • 8.3.3.2.4. By Molecule
      • 8.3.3.2.5. By Application
      • 8.3.3.2.6. By Usage
      • 8.3.3.2.7. By End User
  • 8.3.4. South Korea Single-Use Bioreactors Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Type of Cell
      • 8.3.4.2.4. By Molecule
      • 8.3.4.2.5. By Application
      • 8.3.4.2.6. By Usage
      • 8.3.4.2.7. By End User
  • 8.3.5. Australia Single-Use Bioreactors Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Type of Cell
      • 8.3.5.2.4. By Molecule
      • 8.3.5.2.5. By Application
      • 8.3.5.2.6. By Usage
      • 8.3.5.2.7. By End User

9. South America Single-Use Bioreactors Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
  • 9.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
  • 9.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
  • 9.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
  • 9.2.5. By Application (Research and Development, Bioproduction)
  • 9.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
  • 9.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
  • 9.2.8. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Single-Use Bioreactors Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Type of Cell
      • 9.3.1.2.4. By Molecule
      • 9.3.1.2.5. By Application
      • 9.3.1.2.6. By Usage
      • 9.3.1.2.7. By End User
  • 9.3.2. Argentina Single-Use Bioreactors Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Type of Cell
      • 9.3.2.2.4. By Molecule
      • 9.3.2.2.5. By Application
      • 9.3.2.2.6. By Usage
      • 9.3.2.2.7. By End User
  • 9.3.3. Colombia Single-Use Bioreactors Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Type of Cell
      • 9.3.3.2.4. By Molecule
      • 9.3.3.2.5. By Application
      • 9.3.3.2.6. By Usage
      • 9.3.3.2.7. By End User

10. Middle East and Africa Single-Use Bioreactors Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
  • 10.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
  • 10.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
  • 10.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
  • 10.2.5. By Application (Research and Development, Bioproduction)
  • 10.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
  • 10.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
  • 10.2.8. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Single-Use Bioreactors Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Type of Cell
      • 10.3.1.2.4. By Molecule
      • 10.3.1.2.5. By Application
      • 10.3.1.2.6. By Usage
      • 10.3.1.2.7. By End User
  • 10.3.2. Saudi Arabia Single-Use Bioreactors Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Type of Cell
      • 10.3.2.2.4. By Molecule
      • 10.3.2.2.5. By Application
      • 10.3.2.2.6. By Usage
      • 10.3.2.2.7. By End User
  • 10.3.3. UAE Single-Use Bioreactors Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Type of Cell
      • 10.3.3.2.4. By Molecule
      • 10.3.3.2.5. By Application
      • 10.3.3.2.6. By Usage
      • 10.3.3.2.7. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.1.1 Growing demand for lab automation activities
• 11.1.2 Growing adoption of lab informatics by biobanks
• 11.1.3 Growing introduction of technologically advanced software services
• 11.2. Challenges
• 11.2.1 Lack of integration standards for laboratory informatics
• 11.2.2 Stringent Regulations

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Single-Use Bioreactors Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. ABEC, INC.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Able Corporation & Biott Corporation.
• 15.3. BBI-Biotech Gmbh.
• 15.4. Cellexus Biosystems PLC.
• 15.5. Celltainer Biotech BV.
• 15.6. Danaher Corporation
• 15.7. Distek Inc.
• 15.8. Eppendorf AG.
• 15.9. G&G Technologies, Inc.
• 15.10. Getinge AB

16. Strategic Recommendations

17. About Us & Disclaimer